Elevance Health, Inc. - COM (ELV)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
202M
Holdings value Q3 2024
$105B
Value change Q3 2024
-$3.67B
Grand Portfolio weight change Q3 2024
-0.007%
Number of holders
1652
Number of buys Q3 2024
773
Number of sells Q3 2024
-716
Average buys Q3 2024 %
+0.008%
Average sells Q3 2024 %
-0.04%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 202M $105B -$3.67B $520.00 1,659
2024 Q2 207M $112B +$2.77B $541.86 1,686
2024 Q1 203M $105B -$2.47B $518.54 1,634
2023 Q4 208M $97.9B +$1.11B $471.56 1,623
2023 Q3 205M $89.3B -$1.8B $435.42 1,498
2023 Q2 209M $92.8B -$412M $444.29 1,491
2023 Q1 210M $96.5B -$1.14B $459.81 1,482
2022 Q4 212M $109B -$465M $512.97 1,523
2022 Q3 213M $96.7B -$267M $454.24 1,406
2022 Q2 213M $103B +$238M $482.58 1,420
2022 Q1 214M $105B +$474M $491.22 1,399
2021 Q4 214M $98.9B -$701M $463.54 1,355
2021 Q3 215M $80.3B -$324M $372.80 1,197
2021 Q2 216M $82.5B -$203M $381.80 1,214
2021 Q1 217M $77.8B -$12.8M $358.95 1,191
2020 Q4 217M $69.5B -$1.21B $321.09 1,151
2020 Q3 222M $59.5B -$814M $268.59 1,065
2020 Q2 224M $58.9B +$720M $262.98 1,083
2020 Q1 222M $50.4B -$270M $227.04 1,020
2019 Q4 222M $67.2B -$898M $302.03 1,092
2019 Q3 226M $54.1B -$552M $240.10 998
2019 Q2 228M $64.1B +$1.54B $282.21 1,019
2019 Q1 226M $64.9B -$572M $286.98 1,058
2018 Q4 228M $59.9B +$652M $262.63 987
2018 Q3 227M $62.2B -$80.7M $274.05 940
2018 Q2 228M $54.2B +$476M $238.03 919
2018 Q1 226M $49.6B +$137M $219.70 916
2017 Q4 226M $50.8B -$185M $225.01 905
2017 Q3 227M $43B -$966M $189.88 839
2017 Q2 235M $44.2B -$688M $188.13 839
2017 Q1 237M $39.3B +$4.2B $165.38 782
2016 Q4 236M $34B +$110M $143.77 769
2016 Q3 233M $29.2B -$483M $125.31 719
2016 Q2 237M $31.2B +$193M $131.34 744
2016 Q1 236M $32.7B -$93.8M $138.99 757
2015 Q4 237M $33B +$246M $139.44 752
2015 Q3 235M $32.9B +$994M $140.00 750
2015 Q2 227M $37.3B -$965M $164.14 771
2015 Q1 233M $36B -$91.1M $154.41 740
2014 Q4 235M $29.5B +$29.4B $125.67 697
2014 Q3 60.8K $7.28M $0 $119.61 1
2014 Q2 60.8K $6.54M +$616K $107.59 1
2014 Q1 55.1K $5.48M +$2.38M $99.54 1